Showing results (1011-1020 of 1,381) with videos related to

Sort By:
Pageof 139
Cureus|August 7, 2023
A Case of Type V Hyperlipoproteinemia Resistant to Insulin TreatmentShaunak Mangeshkar, Natalia Nazarenko, Dimitrios Varrias, et al.
Frontiers in Medicine|September 1, 2023
Tai Chi exercise reduces circulating levels of inflammatory oxylipins in postmenopausal women with knee osteoarthritis: results from a pilot studyChwan-Li Shen, John W Newman, Moamen M Elmassry, et al.
Nucleic Acids Research|October 29, 2004
Application of locked nucleic acids to improve aptamer in vivo stability and targeting functionKathrin S Schmidt, Sandra Borkowski, Jens Kurreck, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 14, 2017
Deletion of CD73 in mice leads to aortic valve dysfunctionP Zukowska, B Kutryb-Zajac, A Jasztal, et al.
Physical Review Letters|March 11, 2017
Quantitative Agreement between Electron-Optical Phase Images of WSe_{2} and Simulations Based on Electrostatic Potentials that Include Bonding EffectsS Borghardt, F Winkler, Z Zanolli, et al.
American Journal of Industrial Medicine|April 23, 2013
Effects of social, economic, and labor policies on occupational health disparitiesCarlos Eduardo Siqueira, Megan Gaydos, Celeste Monforton, et al.
Phytotherapy Research : PTR|April 24, 2007
Gedunin, a limonoid from Xylocarpus granatum, inhibits the growth of CaCo-2 colon cancer cell line in vitroShaikh J Uddin, Lutfun Nahar, Jamil A Shilpi, et al.
International Journal of Medical Microbiology : IJMM|July 28, 2018
Capsule and fimbriae modulate the invasion of Haemophilus influenzae in a human blood-cerebrospinal fluid barrier modelSvenja Häuser, Christian Wegele, Carolin Stump-Guthier, et al.
Infectious Agents and Cancer|January 16, 2015
The first case of human autochtonous subconjunctival dirofilariosis in Poland and MALT lymphoma as possible consequence of this parasitosisPiotr K Borkowski, Grzegorz Rymkiewicz, Joanna Golebiewska, et al.
Human Vaccines & Immunotherapeutics|May 4, 2023
Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trialPio López, Eduardo López-Medina, Xavier Sáez-Llorens, et al.
Pageof 139